PDP1 and tuberculosis: Motivated by a desire to develop an inhaled PAE dry powder to treat TB, the studies presented here revealed inhaled PDP, a dry powder combination of POA and PAE, as working at low levels compared to standard oral therapies, having local and systemic effects and being distinguished by a better ability to resolve necrotic granulomas than other therapies.